Hui L Li

20100332499, Dec 30, 2010

Jun 26, 2009

12/493097

Yufei Pan - North Brunswick NJ, US
Hui Li - Edison NJ, US
Justin Sarma - New York NY, US
David Soukal - Bothell WA, US
Alessio Signorini - Boulder CO, US
Apostolos Gerasoulis - Edison NJ, US
Tomasz Imielinski - Princeton NJ, US

IAC SEARCH & MEDIA, INC. - New York NY

G06F 17/30

707759, 707769

In a method for a direct answer for search, a search query is received over a network, one or more answer candidate snippets for the search query are received, with an answer candidate snippet having at least a portion of content available over the network for an answer candidate, one or more answer entities are determined within a selected answer candidate snippet, a frequency of the one or more answer entities found within the one or more answer candidate snippets for the search query is determined, a confidence score is adjusted for the selected answer candidate in accordance with the frequency of the one or more answer entities found within the one or more answer candidate snippets, and at least one answer candidate snippet is sent for a response to the search query.

20210017171, Jan 21, 2021

Jun 26, 2020

16/914209

- South San Francisco CA, US
Chengguo DONG - Staten Island NY, US
Timothy HOM - Sunnyvale CA, US
Lan JIANG - Foster City CA, US
Katerina LEFTHERIS - San Mateo CA, US
Hui LI - Santa Clara CA, US
Manuel MUNOZ - Vallejo CA, US
Maureen REILLY - Burlingame CA, US
Yajun ZHENG - Foster City CA, US

C07D 471/04
C07D 519/00

The invention relates to compounds of formula (A) and formula (I):or a salt thereof, wherein R, R, R, R, R, R, R, R, R, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).

20200352942, Nov 12, 2020

Apr 8, 2020

16/843824

- South San Francisco CA, US
Chengguo DONG - Staten Island NY, US
Timothy HOM - Sunnyvale CA, US
Lan JIANG - Foster City CA, US
Katerina LEFTHERIS - San Mateo CA, US
Hui LI - Santa Clara CA, US
Manuel MUNOZ - Vallejo CA, US
Maureen REILLY - Burlingame CA, US
Yajun ZHENG - Foster City CA, US
Martin DECARIS - Oakland CA, US
Scott TURNER - Oakland CA, US

A61K 31/5025
A61K 31/502
A61K 31/4375
A61K 9/00
A61P 11/00

The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I):or a salt thereof, wherein R, R, R, R, R, R, R, R, R, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).

20190276449, Sep 12, 2019

Mar 7, 2019

16/296194

- South San Francisco CA, US
Chengguo DONG - Staten Island NY, US
Timothy HOM - Sunnyvale CA, US
Lan JIANG - Foster City CA, US
Katerina LEFTHERIS - San Mateo CA, US
Hui LI - Santa Clara CA, US
Manuel MUNOZ - Vallejo CA, US
Maureen REILLY - Burlingame CA, US
Yajun ZHENG - Foster City CA, US

C07D 471/04
C07D 519/00

The invention relates to compounds of formula (A) and formula (I):or a salt thereof, wherein R, R, R, R, R, R, R, R, R, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).